105
Participants
Start Date
September 30, 2014
Primary Completion Date
January 30, 2020
Study Completion Date
January 30, 2020
Modufolin (arfolitixorin)
IV injection every second week for 8 weeks.
Fluorouracil
IV injection every second week for 8 weeks.
Oxaliplatin
IV infusion every second week for 8 weeks.
Irinotecan
IV infusion every second week for 8 weeks.
Bevacizumab
IV infusion every second week for 8 weeks.
Odense University Hospital, Odense
251 General Airforce Hospital, Athens
Medical School University of Athens, Aretaieio Hospital, Athens
Metropolitan General Hospital, Athens
University Genral Hospital Attikon, Athens
University General Hospital of Heraklion, Irakleio
Oslo University Hospital - Radiumhospitalet, Oslo
Oslo University Hospital - Ullevål, Oslo
Skaraborg hospital, Skövde
Sahlgrenska University Hospital, Gothenburg
Lead Sponsor
Isofol Medical AB
INDUSTRY